D-0784-2016 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0784-2016 was initiated by Dr. Reddy's Laboratories, Inc. on Mar 3, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial The recall status is terminated (terminated May 3, 2017). Affected quantity: 3,342 vials.

Recall details

Product Type
Drugs
Report Date
Apr 6, 2016
Initiation Date
Mar 3, 2016
Termination Date
May 3, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,342 vials

Product description

Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL), 100 mL Single Use Bottle, Rx Only, Mfd. By: Gland Pharma Limited D.P. Pally - 500 043 INDIA NDC 55111-688-52

Reason for recall

Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial

Distribution pattern

Nationwide

Code information

Lot BS523, exp 10/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0784-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0784-2016. Report a data issue: hello@regdatalab.com.